Evidence map›Paper›PMID 15492925›Full record

ArticleAmerican journal of human genetics2004

Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation.

Linda S Weaving, John Christodoulou, Sarah L Williamson, Kathie L Friend, Olivia L D McKenzie, Hayley Archer, Julie Evans, Angus Clarke, Gregory J Pelka, Patrick P L Tam and 6 more

2 registry-linked trialsOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in American journal of human genetics, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 187 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
187citing papers in PubMed, 2 pooled it
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02705677 completednot on this mapstarted 2017, after this paper: background citation

Biobanking of Rett Syndrome and Related Disorders Protocol

TypeobservationalSponsorUniversity of Alabama at BirminghamRan2017 to 2021Enrolled752ConditionsRett Syndrome, MECP2 Duplication, CDKL5, FOXG1 Disorders
NCT02738281 completednot on this mapstarted 2015, after this paper: background citation

Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol

TypeobservationalSponsorUniversity of Alabama at BirminghamRan2015 to 2021Enrolled1,044ConditionsRett Syndrome, MECP2 Duplication dIsorder, CDKL5 Disorder, FOXG1 Syndrome
3 · Its place in the literature

Who cites it

187 citing papers in PubMed, 2 syntheses or guidelines pooled it, 498 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Human mutation · 2025
    Article
  17. Rett syndrome.Nature reviews. Disease primers · 2024
    Review
  18. Clinical trials for Lennox-Gastaut syndrome: Challenges and priorities.Annals of clinical and translational neurology · 2024
    Review
  19. Review
  20. Review

127 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Linda S WeavingWestern Sydney Genetics Program, the Children's Hospital at Westmead, New South Wales, Australia.
John Christodoulou
Sarah L Williamson
Kathie L Friend
Olivia L D McKenzie
Hayley Archer
Julie Evans
Angus Clarke
Gregory J Pelka
Patrick P L Tam
Catherine Watson
Hooshang Lahooti
Carolyn J Ellaway
Bruce Bennetts
Helen Leonard
Jozef Gécz
Children's Hospital at Westmead · AUChildren's Medical Research Institute · AUUniversity of Sydney · AUUniversity of Wales · GBWomen's and Children's Hospital · AUThe Kids Research Institute Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rett syndrome (RTT) is a severe neurodevelopmental disorder caused, in most classic cases, by mutations in the X-linked methyl-CpG-binding protein 2 gene (MECP2). A large degree of phenotypic variation has been observed in patients with RTT, both those with and without MECP2 mutations. We describe a family consisting of a proband with a phenotype that showed considerable overlap with that of RTT, her identical twin sister with autistic disorder and mild-to-moderate intellectual disability, and a brother with profound intellectual disability and seizures. No pathogenic MECP2 mutations were found in this family, and the Xq28 region that contains the MECP2 gene was not shared by the affected siblings. Three other candidate regions were identified by microsatellite mapping, including 10.3 Mb at Xp22.31-pter between Xpter and DXS1135, 19.7 Mb at Xp22.12-p22.11 between DXS1135 and DXS1214, and 16.4 Mb at Xq21.33 between DXS1196 and DXS1191. The ARX and CDKL5 genes, both of which are located within the Xp22 region, were sequenced in the affected family members, and a deletion of nucleotide 183 of the coding sequence (c.183delT) was identified in CDKL5 in the affected family members. In a screen of 44 RTT cases, a single splice-site mutation, IVS13-1G-->A, was identified in a girl with a severe phenotype overlapping RTT. In the mouse brain, Cdkl5 expression overlaps--but is not identical to--that of Mecp2, and its expression is unaffected by the loss of Mecp2. These findings confirm CDKL5 as another locus associated with epilepsy and X-linked mental retardation. These results also suggest that mutations in CDKL5 can lead to a clinical phenotype that overlaps RTT. However, it remains to be determined whether CDKL5 mutations are more prevalent in specific clinical subgroups of RTT or in other clinical presentations.

Indexed as

Amino Acid SequenceAnimalsBase SequenceBlotting, WesternBrainChromosomal Proteins, Non-HistoneChromosomes, Human, XDNA-Binding ProteinsDNA PrimersDosage Compensation, GeneticFluorescenceGenetic TestingHaplotypesHeredodegenerative Disorders, Nervous SystemHumansIn Situ HybridizationCDKL5 protein, humanChromosomal Proteins, Non-HistoneDNA-Binding ProteinsDNA PrimersMECP2 protein, humanMecp2 protein, mouseMethyl-CpG-Binding Protein 2Protein Serine-Threonine KinasesRepressor Proteins

Identifiers

PMID15492925
PMCPMC1182143
OpenAlexW2066779634

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.